For decades against the mainstream – From erythropoietin and hypoxia as novel treatment strategies to deep phenotyping in neuropsychiatric disorders

2022 | journal article; discussion. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​For decades against the mainstream – From erythropoietin and hypoxia as novel treatment strategies to deep phenotyping in neuropsychiatric disorders​
Ehrenreich, H. ​ (2022) 
Psychiatry Research, 317 art. 114854​.​ DOI: https://doi.org/10.1016/j.psychres.2022.114854 

Copy

Further links

Documents & Media

License

Published Version

Usage license

Details

Authors
Ehrenreich, Hannelore 
Issue Date
2022
Journal
Psychiatry Research 
Project
TRR 274: Checkpoints of Central Nervous System Recovery 
TRR 274 | C01: Oligodendroglial NMDA receptors and NMDAR1 autoantibodies as determinants of axonal integrity in neuropsychiatric disease 
Organization
Max-Planck-Institut für Multidisziplinäre Naturwissenschaften 
Working Group
RG Ehrenreich (Clinical Neuroscience) 
ISSN
0165-1781
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media